Cognition Disorders
86
4
5
56
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Research Maturity
56 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.1%
7 terminated out of 86 trials
88.9%
+2.4% vs benchmark
15%
13 trials in Phase 3/4
18%
10 of 56 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 56 completed trials
Clinical Trials (86)
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
Brain Stimulation and Cognitive Training for MCI
Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults
Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive Impairment
The Effect of tDCS Combined With TMS on Cognitive Impairment and Motor Function After Stroke
MRI Technical Development and Applications in Kidney Disease
Influence of Individual Traits on Adaptation Processes in Individuals With Alcohol Use Disorder
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
Westlake Aging Cohort (WeAC)
Dual-Task Improvement in Parkinson's Via rTMS
Neuropsychological Outcome After Cardiac Arrest
Supplementation of Inulin + L. Acidophilus in Elders with T2DM
Schizophrenia Cognition Scale Development
Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool
Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
Digital Game: A Scale to Evaluate the Perioperative Cognitive Function
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study